Sharck Soup Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Sharck Soup

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: GREENLAW4-7 who wrote (33411)	8/23/2001 11:39:34 AM
From: Dr. Voodoo	Read Replies (2) of 37746

With all due respect. I disagree. You do not understand the science, and I guarantee nobody here wants to debate it with me. Biotech is a long term investment, equate antisense with a trip to the moon, and you just about have it. This isn't mab and this isn't protein therapeutics. It's complicated and they will have their ups and downs. This is just a runup pump. Have fun making money. But the cash inflow keeps Isis afloat until the next 3 NDA's have the potential to be approved. And thus should be considered in the bottom line with respect to valuation. Thus, follow the tide. If pos's like HGSI are worth 47.... I give them even odds with anybody else for approval. They have one drug on the market--they know the regulatory hoops. You forgot psoriasis, and Chrohn's with off label potential for Rheumatoid arthritis. Voodoo

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next